Predicting transition from oral pre-malignancy to malignancy via Bcl-2 immuno-expression: Evidence and lacunae
Bcl-2 (B cell Lymphoma −2) family comprises of both anti-apoptotic and pro-apoptotic proteins whose altered expression or change in ratio inhibits apoptosis, and promotes tumor progression. The aim of this study is to assess the usefulness of Bcl-2 in distinguishing dysplastic or malignant epitheliu...
Saved in:
| Main Authors: | Ruby Dwivedi, Shaleen Chandra, Divya Mehrotra, Vineet Raj, Rahul Pandey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-10-01
|
| Series: | Journal of Oral Biology and Craniofacial Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2212426820300944 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bcl-2 expression and image analysis of premalignant and malignant colonic lesions
by: Sonia L. El-Sharkawy, et al.
Published: (2024-01-01) -
Expression of p63 in potentially malignant and malignant oral lesions
by: Anju Sinha, et al.
Published: (2015-09-01) -
Expression and bioinformatics analyses show HSP70 complements BCL2 action in oral carcinogenesis
by: Geeta Singh, et al.
Published: (2022-09-01) -
A Comparative Study of Bcl-2 Expression in Oral Leukoplakia with Dysplasia, Verrucous Carcinoma, and Oral Squamous Cell Carcinoma
by: Bireswar Roy, et al.
Published: (2024-12-01) -
Evaluating the role of CD44 in oral squamous cell carcinoma and potentially malignant disorders – An immunohistochemical study
by: Tharani V, et al.
Published: (2024-06-01)